Glaxosmithkline Share News (GSK)

FDA panel votes in favor of approval of Glaxo lung drug Anoro

WASHINGTON, Sept 10 (Reuters) - An federal advisory panel has recommended that the U.S. Food and Drug Administration approve a drug made by GlaxoSmithKline Plc and Theravance Inc to treat chronic obstructive pulmonary disease. The panel voted 11-2 to approve the drug, Anoro, an inhaled comb

ChemoCentryx shares tumble on mixed results for kidney disease drug

Sept 10 (Reuters) - ChemoCentryx Inc's experimental drug for treating diabetic kidney disease showed mixed results in a mid-stage trial with a higher dose being less effective than a lower one, sending the company's stock tumbling by as much as 27 percent. The interim trial data showed that

London close: Stocks jump to four-week high as Syria concerns ease

The FTSE 100 jumped to a four-week high on Tuesday as investors' fears of an impending US military strike on Syria eased and the economic outlook for China improved. London's benchmark index finished 53.25 points higher at 6,583.99, a gain of 0.82%; the last time it closed higher was on August 14th

FTSE 100 movers: easyJet leaps on CEO interview

easyJet shares are firmly on the rise, extending yesterday's gain of around one per cent. The company has said it's geared up to take on other low-cost airlines across Europe, saying it expects other airlines will have difficulty in embracing a no-frills style. It said the loss of as many as 86m sho

MARKET PULSE-McDonald's, Crocs, Amicus, Urban Outfitters, Pep Boys

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) Sept. 10 (Reuters) - Some U.S. stocks to watch on Tuesday: FUTURES CLIMB ON ROSY CHINA

MARKET PULSE-McDonald's, Apple, Model N, Neurocrine, HD Supply, AMD

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) Sept. 10 (Reuters) - Some U.S. stocks to watch on Tuesday: FUTURES CLIMB ON ROSY CHINA

Glaxo blockbuster Advair faces US copycats after FDA greenlight

A report from the US drugs regulator has threatened to open up competition for GlaxoSmithKline's best-selling drug. Shares in the pharmaceuticals giant fell more than 3% after a report from the US Food and Drug Administration (FDA) suggested generic drugs identical to GSK's blockbuster asthma drug

London midday: FTSE 100 nears one-month high

Receding fears about a potential US military strike on Syria and decent data from China lifted UK stocks on Thursday morning, with the FTSE 100 rising to levels not seen in nearly a month. London's benchmark index was up 0.8% at 6,581.91 by midday; the last time it closed higher was on August 14th

UPDATE 1-GSK shares hit as Advair generic threat grows in U.S.

UPDATE 1-GSK shares hit as Advair generic threat grows in U.S.

* FDA draft document points way to generic drug substitutes * $8 bln-a-year lung drug accounts for fifth of GSK sales * GSK says significant hurdles remain for Advair generics * Shares down as much as 3.6 pct, biggest fall in 20 months (Adds GSK comment, details, latest shares

REFILE-MARKET PULSE-Neurocrine Biosciences, AMD, L&L Energy, BlackBerry, Microsoft

(Corrects link to market report) Sept. 10 (Reuters) - Some U.S. stocks to watch on Tuesday: FUTURES CLIMB ON ROSY CHINA DATA, EASING SYRIA FEARS U.S. stock index futures rose on Tuesday, putting the S&P 500 on track for a sixth day of gains, following another batch of rosy econo

MARKET PULSE-Neurocrine Biosciences, AMD, L&L Energy, BlackBerry, Microsoft

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s) Sept. 10 (Reuters) - Some U.S. stocks to watch on Tuesday: FUTURES CLIMB ON ROSY CHINA DATA, EASING SYRIA FEARS U.S. stock index futures rose on Tuesda

GSK shares hit as Advair generics edge closer in U.S.

LONDON, Sept 10 (Reuters) - The threat of generic copies of GlaxoSmithKline's best-selling lung drug Advair finally making it to market in the United States hit confidence in the drugmaker on Tuesday, sending the stock down more than 3 percent. Fears of cheaper versions of the $8 billion-a-

Tuesday broker round-up UPDATE

African Barrick Gold: Investec shifts target price from 135p to 137p, while downgrading from hold to sell. Aquarius Platinum: JP Morgan moves target price from 39p to 49p, while downgrading from neutral to underweight. Citi lowers target price from 66p to 54p and downgrades from buy to neutral. As

FTSE 100 movers: BG falls after warning on Egypt

Oil and gas group BG was a heavy faller today after lowering its 2014 production milestones due to the instability in Egypt, delays to the start-up of production in Norway and low natural gas prices in the US. Food ingredients peer and retail group Associated British Foods was also lower despite s